{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:23:21Z","timestamp":1648650201318},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.dsx.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T10:35:09Z","timestamp":1425638109000},"page":"244-246","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changes of the glycemic control and therapeutic regimen for diabetes mellitus in the Japanese patients on hemodialysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Toru","family":"Sanai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toma","family":"Fukumitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2015.02.012_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4009\/jsdt.46.1","article-title":"For statistical survey committee of Jpn Soc Dial Ther: an overview of dialysis treatment in Japan (as of December 31, 2011)","volume":"46","author":"Nakkai","year":"2013","journal-title":"J Jpn Soc Dial"},{"key":"10.1016\/j.dsx.2015.02.012_bib0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diabres.2008.11.038","article-title":"Glycemic control and survival on diabetic hemodialysis patients \u2013 importance of lower hemoglobin A1c levels","volume":"83","author":"Ishimura","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2015.02.012_bib0105","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/dc06-2127","article-title":"A1c and survival in maintenance hemodialysis patients","volume":"30","author":"Kalnatar-Zadeh","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2015.02.012_bib0110","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s00125-007-0650-z","article-title":"Diabetes, glycemic control and mortality risk in patients hemodialysis: the Japan dialysis outcome and practice pattern study","volume":"50","author":"Hayashino","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2015.02.012_bib0115","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/ndt\/12.10.2105","article-title":"Poor predialysis glyceamic control is a predictor of mortality in type II diabetic patients on maintenance heamodialysis","volume":"12","author":"Wu","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dsx.2015.02.012_bib0120","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diacare.24.5.909","article-title":"Glycemic control is a predictor of survival for diabetic patients on hemodialysis","volume":"24","author":"Morioka","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2015.02.012_bib0125","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s00125-006-0416-z","article-title":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus","volume":"49","author":"Raz","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2015.02.012_bib0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2152\/jmi.53.223","article-title":"Indicators for blood glucose control in diabetes with end-stage chronic renal disease: GHb vs glycated albumin (GA)","volume":"53","author":"Chujo","year":"2006","journal-title":"J Med Invest"},{"key":"10.1016\/j.dsx.2015.02.012_bib0135","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2169\/internalmedicine.37.826","article-title":"Influence of erythropoietin treatment on hemodialysis A1c levels in patients chronic renal failure on hemodialysis","volume":"37","author":"Nakao","year":"1998","journal-title":"Intern Med"},{"key":"10.1016\/j.dsx.2015.02.012_bib0140","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1681\/ASN.2006070772","article-title":"Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection","volume":"18","author":"Inaba","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dsx.2015.02.012_bib0145","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ki.2008.25","article-title":"Comparison of glycated albumin and hemoglobin A1c levels in diabetes subject on hemodialysis","volume":"73","author":"Peacock","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.dsx.2015.02.012_bib0150","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ncpneph0881","article-title":"Glycated hemoglobin or glycated albumin for assessment of glycemic control in dialysis patient with diabetes?","volume":"4","author":"Abe","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.dsx.2015.02.012_bib0155","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex difference of endogenous sex hormone and risk of type 2 diabetes","volume":"295","author":"Ding","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.dsx.2015.02.012_bib0160","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc05-1887","article-title":"Impact of glycemic control on survival of diabetic patients in chronic regular hemodialysis","volume":"29","author":"Oomichi","year":"2006","journal-title":"Diabetic Care"},{"key":"10.1016\/j.dsx.2015.02.012_bib0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1463-1326.2008.00914.x","article-title":"Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency","volume":"10","author":"Chan","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dsx.2015.02.012_bib0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/bmj.2.6134.388","article-title":"Severity of coronary sclerosis related to lipoprotein concentration","volume":"2","author":"Jenkin","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.dsx.2015.02.012_bib0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dsx.2015.02.012_bib0180","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T16:30:28Z","timestamp":1537806628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402115000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1871402115000259"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2015.02.012","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes of the glycemic control and therapeutic regimen for diabetes mellitus in the Japanese patients on hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Diabetes India. Published by Diabetes India All rights reserved.","name":"copyright","label":"Copyright"}]}}